ASO Author Reflections: De-escalation of Breast Cancer Surgery-A Leap Forward

Enver Özkurt^{1

2}, Mehra Golshan^{3

4}

Affiliations

¹ Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
² Breast Unit, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Istanbul, Turkey.
³ Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. mgolshan@bwh.harvard.edu.
⁴ Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. mgolshan@bwh.harvard.edu.

Comment

Enver Özkurt et al. Ann Surg Oncol. 2019 Dec.

. 2019 Dec;26(Suppl 3):711-712.

doi: 10.1245/s10434-019-07759-0. Epub 2019 Aug 29.

Enver Özkurt^{1

2}, Mehra Golshan^{3

4}

¹ Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
² Breast Unit, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Topkapi, Istanbul, Turkey.
³ Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. mgolshan@bwh.harvard.edu.
⁴ Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. mgolshan@bwh.harvard.edu.

No abstract available

Comment on

Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?
Özkurt E, Sakai T, Wong SM, Tukenmez M, Golshan M. Özkurt E, et al. Ann Surg Oncol. 2019 Oct;26(10):3260-3268. doi: 10.1245/s10434-019-07534-1. Epub 2019 Jul 24. Ann Surg Oncol. 2019. PMID: 31342356